Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
HAE vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 23'rd Jul 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Boston Scientific (BSX). But which of these two stocks offers value investors a better
HAE or BSX: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 22'nd Jul 2024
Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportu
Here's Why Haemonetics (HAE) is a Strong Growth Stock
10:46am, Tuesday, 16'th Jul 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches
12:41pm, Friday, 12'th Jul 2024
Haemonetics (HAE) is gaining from the newly completed limited market release of the new Express Plus technology with more than 60,000 real-world collections.
Top Medical Stocks to Buy for Growth & Performance
06:01pm, Wednesday, 10'th Jul 2024
The medical sector is crawling with opportunity as indicated in its representation on the Zacks Rank #1 (Strong Buy) list.
Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a Bet
10:55am, Wednesday, 10'th Jul 2024
The consensus price target hints at a 33.2% upside potential for Haemonetics (HAE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estima
5 Well-Positioned Relative Price Strength Stocks to Buy Now
08:51am, Wednesday, 10'th Jul 2024
NEP, TREE, HAE, CTRA and WSM are five stocks with explosive relative price strength.
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
04:05pm, Monday, 08'th Jul 2024
BOSTON , July 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, Augu
Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10:35am, Thursday, 27'th Jun 2024
The heavy selling pressure might have exhausted for Haemonetics (HAE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts
Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
03:50pm, Friday, 21'st Jun 2024
Haemonetics faces near-term revenue growth challenges due to the loss of its plasma collections business with CSL over the next two years. Management has used M&A to boost its revenue growth, includin
Haemonetics (HAE) Expands VASCADE Line With New Limited Launch
02:31pm, Wednesday, 19'th Jun 2024
Haemonetics (HAE) expands its VASCADE portfolio with the limited market release of VASCADE MVP XL vascular closure device.
4 Medical Product Stocks to Buy From a Recovering Industry
08:30am, Wednesday, 19'th Jun 2024
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
04:15pm, Tuesday, 18'th Jun 2024
BOSTON , June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launch
HAE vs. BSX: Which Stock Should Value Investors Buy Now?
12:40pm, Friday, 14'th Jun 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Boston Scientific (BSX). But which of these two stocks offers value investors a better
Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Friday, 14'th Jun 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
